US Hospital Acquired infections Market

US Hospital Acquired infections Market Research Report: By Pathogen Type (Bacteria, Viruses, Fungi, Parasites), By Infection Type (Surgical Site Infections, Ventilator-Associated Pneumonia, Catheter-Associated Urinary Tract Infections, Bloodstream Infections), By Hospital Department (Intensive Care Unit, Surgery Department, Emergency Department, Pediatric Department) and By Treatment Type (Infection Control Products, Antibiotics, Disinfectants, Vaccines) - Growth & Industry Forecast 2025 To 2035

Forecast Period
2025 - 2035
CAGR
1.94%
2024 Market Size
$ 8.5 Billion
2035 Market Size
$ 10.5 Billion
Medical Device ● Updated August 2026 Report ID: MRFR/MED/11471-HCR | Pages: 100 | Author: Satyendra Maurya, Garvit Vyas
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Food, Beverages & Nutrition, BY Pathogen Type (USD Billion)
      1. 4.1.1 Bacteria
      2. 4.1.2 Viruses
      3. 4.1.3 Fungi
      4. 4.1.4 Parasites
    2. 4.2 Food, Beverages & Nutrition, BY Infection Type (USD Billion)
      1. 4.2.1 Surgical Site Infections
      2. 4.2.2 Ventilator-Associated Pneumonia
      3. 4.2.3 Catheter-Associated Urinary Tract Infections
      4. 4.2.4 Bloodstream Infections
    3. 4.3 Food, Beverages & Nutrition, BY Hospital Department (USD Billion)
      1. 4.3.1 Intensive Care Unit
      2. 4.3.2 Surgery Department
      3. 4.3.3 Emergency Department
      4. 4.3.4 Pediatric Department
    4. 4.4 Food, Beverages & Nutrition, BY Treatment Type (USD Billion)
      1. 4.4.1 Infection Control Products
      2. 4.4.2 Antibiotics
      3. 4.4.3 Disinfectants
      4. 4.4.4 Vaccines
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Johnson & Johnson (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Becton Dickinson and Company (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 3M Company (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Medtronic plc (IE)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Stryker Corporation (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Abbott Laboratories (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Cardinal Health, Inc. (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Thermo Fisher Scientific Inc. (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY PATHOGEN TYPE
    3. 6.3 US MARKET ANALYSIS BY INFECTION TYPE
    4. 6.4 US MARKET ANALYSIS BY HOSPITAL DEPARTMENT
    5. 6.5 US MARKET ANALYSIS BY TREATMENT TYPE
    6. 6.6 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
    9. 6.9 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
    11. 6.11 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
    12. 6.12 FOOD, BEVERAGES & NUTRITION, BY PATHOGEN TYPE, 2024 (% SHARE)
    13. 6.13 FOOD, BEVERAGES & NUTRITION, BY PATHOGEN TYPE, 2024 TO 2035 (USD Billion)
    14. 6.14 FOOD, BEVERAGES & NUTRITION, BY INFECTION TYPE, 2024 (% SHARE)
    15. 6.15 FOOD, BEVERAGES & NUTRITION, BY INFECTION TYPE, 2024 TO 2035 (USD Billion)
    16. 6.16 FOOD, BEVERAGES & NUTRITION, BY HOSPITAL DEPARTMENT, 2024 (% SHARE)
    17. 6.17 FOOD, BEVERAGES & NUTRITION, BY HOSPITAL DEPARTMENT, 2024 TO 2035 (USD Billion)
    18. 6.18 FOOD, BEVERAGES & NUTRITION, BY TREATMENT TYPE, 2024 (% SHARE)
    19. 6.19 FOOD, BEVERAGES & NUTRITION, BY TREATMENT TYPE, 2024 TO 2035 (USD Billion)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PATHOGEN TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY INFECTION TYPE, 2025-2035 (USD Billion)
      3. 7.2.3 BY HOSPITAL DEPARTMENT, 2025-2035 (USD Billion)
      4. 7.2.4 BY TREATMENT TYPE, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1
Share::
WhatsApp icon
LinkedIn icon
X (Twitter) icon
ChatGPT icon
Perplexity icon
Request Free Sample

US Hospital Acquired infections Market Segmentation

US Hospital Acquired infections Market By Pathogen Type (USD Billion, 2025-2035)

  • Bacteria
  • Viruses
  • Fungi
  • Parasites

US Hospital Acquired infections Market By Infection Type (USD Billion, 2025-2035)

  • Surgical Site Infections
  • Ventilator-Associated Pneumonia
  • Catheter-Associated Urinary Tract Infections
  • Bloodstream Infections

US Hospital Acquired infections Market By Hospital Department (USD Billion, 2025-2035)

  • Intensive Care Unit
  • Surgery Department
  • Emergency Department
  • Pediatric Department

US Hospital Acquired infections Market By Treatment Type (USD Billion, 2025-2035)

  • Infection Control Products
  • Antibiotics
  • Disinfectants
  • Vaccines
Share::
WhatsApp icon
LinkedIn icon
X (Twitter) icon
ChatGPT icon
Perplexity icon
Request Free Sample

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.